- Home
- FSI
FSI
Flexible Solutions International Inc. (CDA)
as 07-26-2024 4:00pm EST
| Founded: | N/A | Country: | Canada |
| Employees: | N/A | City: | VICTORIA B C |
| Market Cap: | N/A | IPO Year: | 1999 |
| Target Price: | N/A | AVG Volume (30 days): | 24.8K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | Dividend Payout Frequency: | Annual | |
| EPS: | 0.19 | EPS Growth: | -62.75 |
| 52 Week Low/High: | $1.36 - $2.96 | Next Earning Date: | 08-14-2024 |
| Revenue: | $37,702,161 | Revenue Growth: | -16.04% |
| Revenue Growth (this year): | 11.2% | Revenue Growth (next year): | 13.01% |
Stock Insider Trading Activity of Flexible Solutions International Inc. (CDA) (FSI)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| O BRIEN DANIEL B | FSI | Chief Executive Officer | Nov 16 '23 | Sell | $1.57 | 94,563 | $148,463.91 | 4,270,156 | SEC Form 4 |
Latest Flexible Solutions International Inc. (CDA) News
FSI Breaking Stock News: Dive into FSI Ticker-Specific Updates for Smart Investing
GlobeNewswire
10 days ago
FSI ANNOUNCES SECOND QUARTER 2024 REVENUE
MT Newswires
2 months ago
Flexible Solutions International Acquires Vial Filling Production Line
GlobeNewswire
2 months ago
FSI ANNOUNCES CAPEX EXPENDITURE TO ACQUIRE A VIAL FILLING LINE FOR INJECTABLE DRUGS SUCH AS GLP1 FOR WEIGHT LOSS
Zacks
2 months ago
Flexible Solutions (FSI) Q1 Earnings and Sales Lag Estimates
GlobeNewswire
2 months ago
FSI ANNOUNCES FIRST QUARTER, 2024 FINANCIAL RESULTS
Zacks
3 months ago
Innospec (IOSP) Q1 Earnings Beat Estimates
Zacks
3 months ago
Nutrien (NTR) Beats Q1 Earnings and Revenue Estimates
Zacks
3 months ago
AdvanSix (ASIX) Reports Q1 Loss, Misses Revenue Estimates
Compare FSI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "FSI Flexible Solutions International Inc. (CDA) - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.